State Street Corp Oragenics Inc Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $7.35 $59,467 - $3.64 Million	-495,563 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.33 - $0.56 $12,321 - $20,909	37,338 Added 8.15%	495,563 $171,000
Q3 2021 Nov 15, 2021	BUY	$0.58 - $0.84 $2,262 - $3,276	3,900 Added 0.86%	458,225 $291,000
Q2 2021 Aug 16, 2021	BUY	$0.6 - $0.89 $272,595 - $404,349	454,325 New	454,325 $321,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $40.7M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.